Back to results
US 10,377,717 B2Granted
Farnesoid X receptor agonists and uses thereof
AssigneeMetacrine, Inc.
InventorsNicholas D. Smith, Steven P. Govek
Life of this patent
Estimating the term…
Abstract
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Claims18
A compound of Formula (IV), or a pharmaceutically acceptable salt or solvate thereof:
- wherein:
- R1 and R2 are each independently selected from H, D, F, C1-C4alkyl, and C1-C4fluoroalkyl;
- ring A is a monocyclic carbocycle;
- each RA is independently selected from H, D, halogen, —CN, —OH, —OR10, —SR10, —S(═O)R11, —S(═O)2R11, —NHS(═O)2R11, —S(═O)2N(R10)2, —C(═O)R11, —OC(═O)R11, —CO2R10, —OCO2R11, —C(═O)N(R10)2, —OC(═O)N(R10)2, —NR10C(═O)N(R10)2, —NR10C(═O)R11, —NR10C(═O)OR11, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C2-C6alkenyl, substituted or unsubstituted C2-C6alkynyl, substituted or unsubstituted C1-C6fluoroalkyl, and substituted or unsubstituted C1-C6heteroalkyl;
- ring B is a bicyclic heterocycle;
- each RB is independently selected from H, D, halogen, —CN, —OH, —OR10, —SR10, —S(═O)R11, —S(═O)2R11, —N(R10)2, —NHS(═O)2R11, —S(═O)2N(R10)2, —C(═O)R11, —OC(═O)R11, —CO2R10, —OCO2R11, —C(═O)N(R10)2, —OC(═O)N(R102, —NR10C(═O)N(R10)2, —NR10C(═O)R11, —NR10C(═O)OR11, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C2-C6alkenyl, substituted or unsubstituted C2-C6alkynyl, substituted or unsubstituted C1-C6fluoroalkyl, and substituted or unsubstituted C1-C6heteroalkyl;
- R3 is selected from substituted or unsubstituted C1-C10alkyl, or substituted or unsubstituted C3-C10cycloalkyl, wherein if R3 is substituted then R3 is substituted with one or more R12 groups;
- each R12 is independently selected from D, halogen, —CN, —NO2, —OR10, —SR10, —S(═O)R11, —S(═O)2R11, —S(═O)2N(R10)2, —NR10S(═O)2R11, —C(═O)R11, —OC(═O)R11, —CO2R10, —OCO2R11, —N(R10)2, —C(═O)N(R10)2, —OC(═O)N(R10)2, —NR10C(═O)R11, —NR10C(═O)OR11, unsubstituted or substituted C1-C10alkyl, unsubstituted or substituted C1-C10fluoroalkyl, unsubstituted or substituted C2-C10alkenyl, unsubstituted or substituted C2-C10alkynyl, unsubstituted or substituted C1-C10heteroalkyl, and unsubstituted or substituted C3-C10cycloalkyl;
- R4 is absent or -L3-Y;
- L3 is absent, —C(R5)(R6)—, —C(R5)(R6)—C(R7)(R8)—, —O—C(R7)(R8)—, or —C(R5)(R6)—O—;
- R5 and R7 are each independently selected from H, D, C1-C4alkyl and C3-C6cycloalkyl;
- or R5 and R7 are taken together with the intervening atoms to form a double bond;
- or R5 and R7 are taken together with the intervening atoms to form an epoxide or a substituted or unsubstituted C3-C6cycloalkyl;
- R6 and R8 are each independently selected from H, D, C1-C4alkyl or C3-C6cycloalkyl;
- Y is -CH2OR9, -C(═O)OR9,
- R9 is selected from H, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C2-C6alkenyl, substituted or unsubstituted C3-C6cycloalkyl, substituted or unsubstituted phenyl, and substituted or unsubstituted heterocycle;
- L1 is absent;
- ring C is phenyl, bicyclic carbocycle, monocyclic 6-membered heteroaryl containing 1-3 N atoms, or bicyclic heterocycle;
- each RC is independently selected from H, D, halogen, —CN, —OH, —OR10, —S(═O)R11, —NO2, —N(R10)2, —S(═O)2R11, —NHS(═O)2R11, —S(═O)2N(R10)2, —C(═O)R11, —OC(═O)R11, —CO2R10, —OCO2R11, —C(═O)N(R10)2, —OC(═O)N(R10)2, —NR10 C(═O)N(R10)2, —NR10C(═O)R11, —NR10(═O)OR11, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C2-C6alkenyl, substituted or unsubstituted C2-C6alkynyl, substituted or unsubstituted C1-C6fluoroalkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted phenyl, and substituted or unsubstituted monocyclic heteroaryl;
- each R10 is independently selected from H, substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6fluoroalkyl, and substituted or unsubstituted C3-C6cycloalkyl;
- or two R10 on the same N atom are taken together with the N atom to which they are attached to form a N-containing heterocycle;
- each R11 is independently selected from substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C1-C6heteroalkyl, substituted or unsubstituted C1-C6fluoroalkyl, substituted or unsubstituted C3-C6cycloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted monocyclic heteroaryl, and substituted or unsubstituted benzyl;
- m is 0, 1, or 2;
- n is 0, 1, or 2;
- and
- p is 0, 1, 2, 3, or 4;
- wherein any substituted group is substituted with one or more groups individually and independently selected from D, halogen, —CN, —NH2, —NH(CH3), —N(CH1)2 —OH, —CO2H, —CO2( C1-C4alkyl), —C(═O)NH2, —C(═O)NH(C1-C4alkyl), —C(═O)N(C1-C4alkyl)2, —S(═O)2NH2, —S(═O)2NH(C1-C4alkyl), —S(═O)2N(C1-C4alkyl)2, C1-C4alkyl, C3-C6cycloalkyl, C1-C4fluoroalkyl, C1-C4heteroalkyl, C1-C4alkoxy, C1-C4fluoroalkoxy, —SC1-C4alkyl, —S(═O)C1-C4alkyl, and —S(═O)2C1-C4alkyl.
24 more elements
Dependencies are inferred from the claim text.